Polo-like kinase 1 phosphorylates and regulates Bcl-xL during pironetin-induced apoptosis

Oncogene

Volumn 28, Issue 1, 2009, Pages 107-116

  Tamura, Y ^a,b   Simizu, S ^a   Muroi, M ^a   Takagi, S ^a,b   Kawatani, M ^a   Watanabe, N ^a   Osada, H ^a,b  

^a RIKEN   (Japan)

^b SAITAMA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bcl xL; Phosphorylation; Pironetin; Plk1

Indexed keywords

ALANINE; POLO LIKE KINASE 1; PROTEIN BCL XL;

APOPTOSIS; ARTICLE; CELL CYCLE M PHASE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; PHOSPHORYLATION; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

ALANINE; APOPTOSIS; BCL-X PROTEIN; CELL CYCLE PROTEINS; CELL LINE, TUMOR; HUMANS; MUTATION; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PYRONES; SERINE;

EID: 58149354672     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.368     Document Type: Article

References (37)

1. Barr FA, Silljé HH, Nigg EA. (2004). Polo-like kinases and the orchestration of cell division. Nat Rev Mol Cell Biol 5: 429-440.
2. Basu A, Haldar S. (2003). Identification of a novel Bcl-xL phosphorylation site regulating the sensitivity of taxolor 2-methoxyestradiol- induced apoptosis. FEBS Lett 538: 41-47.
3. Boise LH, González-García M, Postema CE, Ding L, Lindsten T, Turka LA et al. (1993). bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608.
4. L and Bcl-2. EMBO J 16: 968-977.
5. Chao DT, Korsmeyer SJ. (1998). BCL-2 family: regulators of cell death. Annu Rev Immunol 16: 395-419.
6. Chen J, Dai G, Wang YQ, Wang S, Pan FY, Xue B et al. (2006). Polo-like kinase 1 regulates mitotic arrest after UV irradiation through dephosphorylation of p53 and inducing p53 degradation. FEBS Lett 580: 3626-3630.
7. L. Nature 379: 554-556.
8. L after spinal cord injury. J Neurosci Res 85: 1894-1911.
9. Cory S, Adams JM. (2002). The BCL2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2: 647-656.
10. L deamidation is a critical switch in the regulation of the response to DNA damage. Cell 111: 51-62.
11. Du L, Lyle CS, Chambers TC. (2005). Characterization of vinblastine-induced Bcl-xL and Bcl-2 phosphorylation: evidence for a novel protein kinase and a coordinated phosphorylation/dephosphorylation cycle associated with apoptosis induction. Oncogene 24: 107-117.
12. Elia AE, Rellos P, Haire LF, Chao JW, Ivins FJ, Hoepker K et al. (2003). The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain. Cell 115: 83-95.
13. Feng Y, Hodge DR, Palmieri G, Chase DL, Longo DL, Ferris DK. (1999). Association of polo-like kinase with α-, β- and γ-tubulins in a stable complex. Biochem J 339: 435-442.
14. Gumireddy K, Reddy MV, Cosenza SC, Nathan RB, Baker SJ, Papathi N et al. (2005). ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent. Cancer Cell 7: 275-286.
15. L sequesters its C-terminal membrane anchor in soluble, cytosolic homodimers. EMBO J 23: 2146-2155.
16. L, but not Bcl-2, to the mitochondrial outer membrane. J Cell Biol 160: 53-64.
17. Kawatani M, Imoto M. (2003). Deletion of the BH1 domain of Bcl-2 accelerates apoptosis by acting in a dominant negative fashion. J Biol Chem 278: 19732-19742.
18. Kondoh M, Usui T, Nishikiori T, Mayumi T, Osada H. (1999). Apoptosis induction via microtubule disassembly by an antitumour compound, pironetin. Biochem J 340: 411-416.
19. Liu X, Erikson RL. (2003). Polo-like kinase (Plk) 1 depletion induces apoptosis in cancer cells. Proc Natl Acad Sci USA 100: 5789-5794.
20. L, an inhibitor of programmed cell death. Nature 381: 335-341.
21. Nakajima H, Toyoshima-Morimoto F, Taniguchi E, Nishida E. (2003). Identification of a consensus motif for Plk (Polo-like kinase) phosphorylation reveals Myt1 as a Plk1 substrate. J Biol Chem 278: 25277-25280.
22. Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA et al. (2005). An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435: 677-681.
23. Petros AM, Olejniczak ET, Fesik SW. (2004). Structural biology of the Bcl-2 family of proteins. Biochim Biophys Acta 1644: 83-94.
24. L is phosphorylated in malignant cells following microtubule disruption. Cancer Res 58: 3331-3338.
25. Ree AH, Bratland Å, Nome RV, Stokke T, Fodstad Ø. (2003). Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1. Oncogene 22: 8952-8955.
26. Reed JC. (2002). Apoptosis-based therapies. Nat Rev Drug Discov 1: 111-121.
27. Schinzel A, Kaufmann T, Borner C. (2004). Bcl-2 family members: intracellular targeting, membrane-insertion, and changes in subcellular localization. Biochim Biophys Acta 1644: 95-105.
28. Simizu S, Osada H. (2000). Mutations in the Plk gene lead to instability of Plk protein in human tumour cell lines. Nat Cell Biol 2: 852-854.
29. Simizu S, Takagi S, Tamura Y, Osada H. (2005). RECK-mediated suppression of tumor cell invasion is regulated by glycosylation in human tumor cell lines. Cancer Res 65: 7455-7461.
30. Simizu S, Tamura Y, Osada H. (2004). Dephosphorylation of Bcl-2 by protein phosphatase 2A results in apoptosis resistance. Cancer Sci 95: 266-270.
31. Tamura Y, Simizu S, Osada H. (2004). The phosphorylation status and anti-apoptotic activity of Bcl-2 are regulated by ERK and protein phosphatase 2A on the mitochondria. FEBS Lett 569: 249-255.
32. Tsujimoto Y, Shimizu S. (2000). Bcl-2 family: life-or-death switch. FEBS Lett 466: 6-10.
33. Usui T, Watanabe H, Nakayama H, Tada Y, Kanoh N, Kondoh M et al. (2004). The anticancer natural product pironetin selectively targets Lys352 of α-tubulin. Chem Biol 11: 799-806.
34. Watanabe N, Arai H, Iwasaki J, Shiina M, Ogata K, Hunter T et al. (2005). Cyclin-dependent kinase (CDK) phosphorylation destabilizes somatic Wee1 via multiple pathways. Proc Natl Acad Sci USA 102: 11663-11668.
35. β-TrCP. Proc Natl Acad Sci USA 101: 4419-4424.
36. Wyllie AH, Kerr JF, Currie AR. (1980). Cell death: the significance of apoptosis. Int Rev Cytol 68: 251-306.
37. L mediates changes in mitochondrial morphology. Biophys J 94: 286-297.